In spite of the integration of various medical regiments, such as ACE-inhibitors, β-blockers, the morbidity and mortality of heart failure patients remain staggeringly high, in which more than 80% of heart failure patients have to be hospitalized [2]; 50% of which die within 5 years of the diagnosis [3,4]. This evidence concerns the gene ACE and heart failure.